---
category: listing
circular_id: d1fe6ae6a8f80fe3
date: '2025-08-25'
description: BSE announces listing of 1000 bonus equity shares of Ipca Laboratories
  Ltd kept in abeyance, effective from August 26, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6D1DFB40-1D11-45C8-8686-83C72BE613A6}&noticeno=20250825-30&dt=08/25/2025&icount=30&totcount=65&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Limited number of shares (1000) kept in abeyance with minimal market
  impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250825-30&attachedId=
processing:
  attempts: 1
  content_hash: 29f384ed1aeeff97
  processed_at: '2025-08-25T15:33:18.967048'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-25T12:08:33+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6D1DFB40-1D11-45C8-8686-83C72BE613A6}&noticeno=20250825-30&dt=08/25/2025&icount=30&totcount=65&flag=0
severity: low
source: bse
stocks:
- IPCA
tags:
- bonus-shares
- listing
- ipca-laboratories
- equity-shares
- abeyance
title: Listing of 1000 Bonus Equity Shares kept in abeyance of Ipca Laboratories Ltd
---

## Summary

BSE has announced the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were kept in abeyance. These shares will be available for trading from Tuesday, August 26, 2025.

## Key Points

- 1000 bonus equity shares of Rs. 1/- each are being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers range: 1303453 to 1304452
- Company scrip code: 524494

## Regulatory Changes

No regulatory changes - this is a routine listing of previously issued bonus shares.

## Compliance Requirements

Trading members are informed of the new securities availability for trading.

## Important Dates

- Effective Date: Tuesday, August 26, 2025
- Notice Date: August 25, 2025

## Impact Assessment

Minimal market impact due to the small number of shares (1000) being released from abeyance. This represents a routine administrative action for previously declared bonus shares of Ipca Laboratories.